Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections
Clinical trial NCT03780140 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03780140
- Sponsor
- Shionogi
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.